Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer-Reference-Cited by-同舟云学术

Oncolytic virotherapy armed with an engineered interfering lncRNA exhibits antitumor activity by blocking the epithelial mesenchymal transition in triple-negative breast cancer

Published:2020-06 Issue: Volume:479 Page:42-53
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ang Lin,Guo Lingli,Wang Jin,Huang Jin,Lou Xiaoli,Zhao Min

Funder

2019 Annual Anhui University Natural Science Research Foundation

The Sixth Cycle Medical Key Specialist Construction Funds of Hefei

The Distinguished Young Scholars Fund of Navy Military Medical University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer;Sceneay;Canc. Discov.,2019

2. Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in triple-negative breast cancer;Zhang;Canc. Res.,2019

3. New insights into the implication of epigenetic alterations in the EMT of triple negative breast cancer;Khaled;Cancers,2019

4. Epithelial-mesenchymal transition in breast cancer correlates with high histological grade andtriple-negative phenotype;Jeong;Histopathology,2012

5. Extracellular-signal regulated kinase: a central molecule driving epithelial-mesenchymal transition in cancer;Olea-Flores;Int. J. Mol. Sci.,2019

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency;Breast Cancer Research;2024-09-10

2. miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses;Pharmaceutics;2024-07-25

3. MRPL13 is a metastatic and prognostic marker of breast cancer: a silico analysis accompanied with experimental validation;2024-05-03

4. miRNA-Based Technologies in Cancer Therapy;Journal of Personalized Medicine;2023-11-09

5. microRNA-based Genetic Therapy in Leukemia: Properties, Delivery, and Experimental Models;Current Gene Therapy;2023-08